Viz.ai
About
Viz.ai harnesses the power of artificial intelligence to transform care coordination and improve patient outcomes. Their comprehensive platform features more than 50 FDA-cleared AI algorithms that analyze medical imaging data including CT scans, EKGs, echocardiograms, and more, delivering real-time insights and automated assessments to accelerate diagnosis, streamline workflows, and support faster treatment decisions.
Details
VenSearch Intelligence
Ideal Customer
- Viz.ai is explicitly enterprise-focused, targeting mid-size to large hospitals, health systems, academic medical centers, and integrated delivery networks.
- The majority of the 50 largest U.S. health systems have adopted its platform, and it has no meaningful offering for solo or small independent practices.
Key Differentiators
- Viz.ai's primary differentiators include being the first AI triage platform to receive FDA De Novo clearance (creating a new regulatory category) and the first to obtain CMS Medicare reimbursement for an AI algorithm — establishing a uniquely deep regulatory and reimbursement moat.
- The platform boasts 50+ FDA-cleared algorithms, the broadest regulatory portfolio in medical imaging AI, and is backed by 125+ peer-reviewed publications.
Industries Served
- Viz.ai serves exclusively the healthcare industry, with a strong focus on hospitals, health systems, academic medical centers, and life sciences companies (pharmaceutical and medical device firms).
- Industry-specific specializations span neurovascular, cardiovascular, vascular, pulmonary, oncology, trauma, and radiology care.
Service Coverage
- Viz.ai operates primarily across the United States and Europe, with its platform deployed in nearly 2,000 hospitals and health systems.
- As of late 2025, the platform covers an estimated 230 million+ patient lives, with offices in San Francisco (HQ), Tel Aviv, Heerenveen (Netherlands), and St. Albans (UK).
Partnerships
- Viz.ai has two primary enterprise technology partnerships.
- Its collaboration with Microsoft integrates 50+ AI models into Microsoft's Precision Imaging Network (part of Microsoft Cloud for Healthcare), leveraging PowerScribe, PowerShare, and Azure across 17,000+ connected healthcare facilities.
Company Size & Ownership
- Viz.ai was founded in 2016 by Dr. Chris Mansi (a neurosurgeon) and David Golan, and is headquartered in San Francisco, CA.
- The company has approximately 325–405 employees as of 2025–2026.
Compliance & Certifications
- Viz.ai holds an extensive compliance and certification portfolio.
- The company has completed SOC 2 Type II + HIPAA audits for four consecutive years and achieved ISO 27001:2022 certification along with six additional ISO certificates (22301:2019, 27017:2015, 27018:2019, 27032:2012, 27701:2019, and 27799:2016), covering business continuity, cloud security, privacy information management, and health information security.
Compiled from public sources by VenSearch · Last researched October 14, 2026
Offerings
23 offeringsAcute Coronary Syndrome (ACS)
AI-powered acute coronary syndrome detection as part of the Viz Cardio Suite developed to meet cardiovascular care needs.
Aortic Disease
AI-powered aortic disease detection as part of the Viz Vascular Suite designed to transform patient outcomes in vascular medicine.
Cardiac Amyloidosis
AI-powered cardiac amyloidosis detection as part of the Viz Cardio Suite developed to meet cardiovascular care needs.
Cerebral Aneurysm
AI-powered cerebral aneurysm detection as part of the Viz Neuro Suite to accelerate neurovascular disease diagnosis and treatment.
CT Perfusion (CTP)
AI-powered analysis of CT perfusion imaging as part of the Viz Neuro Suite for neurovascular disease detection and treatment acceleration.
Hemorrhage
AI-powered detection of hemorrhage as part of the Viz Neuro Suite to accelerate neurovascular disease diagnosis and treatment.
Hyperdensity Measurements
AI-powered hyperdensity measurements capability as part of the Viz Neuro Suite for neurovascular disease detection and treatment.
Hypertrophic Cardiomyopathy
AI-powered hypertrophic cardiomyopathy detection as part of the Viz Cardio Suite developed to meet cardiovascular care needs.
Large Vessel Occlusion (LVO)
AI-powered detection capability for large vessel occlusion as part of the Viz Neuro Suite to accelerate stroke care diagnosis and treatment.
Life Sciences Solutions
Customized AI-powered solutions developed in partnership with pharmaceutical and medical device companies for treatable diseases. Includes research optimization, accelerating patient access and adherence, closing gaps in patient care, and clinical trial enrollment support.
Post Acute Stroke
AI-powered post acute stroke care solution available in both Viz Neuro Suite and Viz Cardio Suite to support stroke patient management and treatment.
Pulmonary Embolism
AI-powered pulmonary embolism detection as part of the Viz Vascular Suite designed to transform patient outcomes in vascular medicine.
Viz Agent Studio
A new capability within the Viz.ai One Platform that enables health systems to build, customize, and deploy AI-powered agents for various healthcare workflows.
Viz Assist
A workflow assistant designed to work alongside clinicians, using generative AI to deliver real-time insights and guideline-based recommendations directly within clinical workflows.
Viz Cardio Suite
AI-powered suite of solutions developed to meet cardiovascular needs. Includes capabilities for hypertrophic cardiomyopathy, post acute stroke, acute coronary syndrome, and cardiac amyloidosis.
Viz Neuro Suite
AI-powered suite of solutions to accelerate the detection and treatment of suspected neurovascular diseases. Includes capabilities for cerebral aneurysm, CT perfusion, hemorrhage, hyperdensity measurements, large vessel occlusion, and post acute stroke care.
Viz Oncology Suite
AI-powered suite of solutions for oncology care delivery and patient outcomes improvement.
Viz Pulmonary Suite
The first comprehensive AI-powered solution dedicated to pulmonary care delivery to improve patient outcomes in respiratory medicine.
Viz Radiology Suite
AI-powered suite of solutions designed to accelerate patient diagnosis and treatment, enabling radiologists to optimize their time for informed decisions and recommendations.
Viz Trauma Suite
AI-powered capabilities tailored to meet today's rigorous trauma center guidelines by streamlining communications and improving patient response.
Viz Vascular Suite
AI-powered suite of solutions designed to transform patient outcomes in vascular medicine. Includes capabilities for aortic disease and pulmonary embolism detection and treatment acceleration.
Viz.ai and Microsoft Cloud for Healthcare
Integration solution that brings cloud-powered agility to healthcare by combining Viz.ai's AI capabilities with Microsoft's cloud infrastructure for improved care coordination.
Viz.ai One
The leading AI-powered care coordination solution designed to revolutionize the way patient care is delivered. It is an enterprise platform that auto-detects suspected diseases across a wide range of therapeutic areas in seconds.
Considering Viz.ai?
Our team will work with you to determine if Viz.ai is the right fit for your organization. From research and assessment through procurement negotiation and ongoing vendor management — we handle the entire process at no cost to you.